News

Amyndas Pharmaceuticals Announces Positive Results from a Phase I Trial of its new complement C3 inhibitor AMY-101

Wed, 13/12/2017 - 10:00

Medherant completes £3.8 million funding round

Mon, 11/12/2017 - 10:00

Domainex appoints Chris Brown as Chief Financial Officer

Wed, 06/12/2017 - 08:00

New study shows European biotech companies returning greater investment value than US peers

Tue, 28/11/2017 - 07:30

Synpromics announces collaboration with UCL to develop revolutionary gene therapy for Parkinson’s Disease

Tue, 28/11/2017 - 07:00

Inflection Biosciences and RCSI Enter Research Collaboration to Target Therapy-Resistant Breast Cancer

Thu, 23/11/2017 - 14:14

Pharma Integrates 2017: A New Value Proposition for Pharma

Wed, 22/11/2017 - 11:49

Pharma Integrates 2017 Delivers a Strong Message to Industry

Mon, 20/11/2017 - 13:50

Medherant wins 'Excellence in Science & Technology Award'

Fri, 17/11/2017 - 15:25

Cypralis to present pre-clinical data on novel cyclophilin D inhibitor CC-1233 for acute pancreatitis at the American Pancreatic Association meeting

Thu, 09/11/2017 - 07:30

Pages